Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Endocrinology

Why Do Acromegaly Patients Need Frequent Colonoscopies?

At a Glance

Patients with acromegaly need frequent colonoscopies because excess growth hormone and IGF-1 stimulate rapid cell growth in the colon while preventing the normal clearing of damaged cells. This increases the risk of silent, precancerous colon polyps that must be proactively found and removed.

Excess growth hormone (GH) and insulin-like growth factor-1 (IGF-1) don’t just affect your bones and facial features; they stimulate cellular growth throughout your entire body, including the lining of your colon [1]. This widespread stimulation increases the likelihood of developing colonic polyps, which have the potential to become cancerous if left unchecked [2][3]. Because these polyps rarely cause symptoms, frequent colonoscopies are a proactive and necessary part of managing acromegaly, allowing doctors to safely find and remove polyps before they can become a problem [4].

Acromegaly is driven by chronic, excessive levels of growth hormone (GH) and Insulin-like Growth Factor-1 (IGF-1), hormones that signal cells to grow and divide [5][6].

In a healthy colon, cells lining the intestinal wall constantly replicate, and old or damaged cells are naturally cleared away through a programmed cell death process called apoptosis [7]. However, elevated IGF-1 levels disrupt this delicate balance [8]. The hormone signals your colon cells to multiply more rapidly while simultaneously blocking apoptosis, preventing the body from clearing away abnormal cells [9]. This environment is highly conducive to the formation of preneoplastic colonic lesions—clumps of abnormal cells that form polyps and can eventually turn into colorectal cancer [1][10].

Crucially, these growing polyps are almost always “silent.” They rarely cause pain, bleeding, or digestive changes in their early, treatable stages. Cumulative exposure to excess IGF-1 over time is an independent predictor of cancer development in acromegaly patients [11]. This means the longer your IGF-1 levels remain elevated, the greater the likelihood of polyps forming without you ever feeling them.

Standard Colonoscopy Guidelines for Acromegaly

To manage this risk, medical guidelines recommend specific surveillance protocols for acromegaly patients [12].

  • Baseline Screening: Clinical consensus requires that a screening colonoscopy be performed at the time of your acromegaly diagnosis [1]. This establishes a baseline and addresses any existing polyps that may have developed while the disease was undiagnosed.
  • Tailored Follow-Up: The frequency of future colonoscopies is not one-size-fits-all. It is tailored based on your individual metabolic status and how well your acromegaly is controlled [4].

Your doctor will likely recommend more frequent colonoscopies—often every 3 to 5 years, or sometimes sooner—if you have any of the following risk factors:

  • Active, uncontrolled acromegaly with consistently high IGF-1 or GH levels [4].
  • Polyps discovered and removed during your baseline screening [13].
  • Impaired glucose metabolism, insulin resistance, or metabolic syndrome (a cluster of conditions including high blood pressure, high blood sugar, and abnormal cholesterol) [4].
  • General colorectal risk factors, such as a strong family history of colon polyps or colon cancer.

If your baseline colonoscopy is clear, your IGF-1 levels are well-controlled through treatment, and you have no other risk factors, your care team may recommend a longer interval, often every 5 to 10 years depending on your age and regional guidelines.

While the colonoscopy preparation process (the “bowel prep”) is notoriously unpleasant, it is a temporary and absolutely vital step. A perfectly clean colon ensures your gastroenterologist can spot even the smallest, flattest polyps.

Protecting Your Health

Because the development of new polyps is directly linked to the biological effects of your condition, a colonoscopy is a vital preventive tool rather than just a routine check-up [1]. Removing pre-cancerous polyps prevents those specific lesions from becoming cancerous and significantly reduces your overall risk of colorectal cancer [10]. Strict adherence to your personalized screening schedule, alongside treatments to normalize your IGF-1 levels, are your best defenses against colon complications associated with acromegaly.

Common questions in this guide

Why does acromegaly cause colon polyps?
Elevated levels of growth hormone and IGF-1 in acromegaly signal the cells lining your colon to multiply rapidly. These hormones also block the natural process that clears away old or damaged cells, creating an environment where precancerous polyps can easily form.
How often do I need a colonoscopy if I have acromegaly?
You should have a baseline colonoscopy when first diagnosed with acromegaly. After that, follow-up screenings are usually recommended every 3 to 5 years, though this interval can be extended to 5 to 10 years if your hormone levels are well-controlled and no polyps were found initially.
What are the symptoms of colon polyps in acromegaly?
Colon polyps are almost always silent, meaning they rarely cause symptoms like pain, bleeding, or digestive changes in their early stages. This is why regular screening colonoscopies are critical for finding and removing them before they become cancerous.
Does having metabolic syndrome affect my colonoscopy schedule?
Yes, having metabolic conditions like insulin resistance, high blood sugar, or high blood pressure increases your risk for developing colon polyps. Your doctor will likely recommend more frequent colonoscopy screenings if you have these conditions alongside acromegaly.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What were the specific findings of my baseline colonoscopy, and did you find any pre-cancerous polyps?
  2. 2.Based on my current IGF-1 levels, metabolic health, and family history, exactly how often do I need a follow-up colonoscopy?
  3. 3.Will my gastroenterologist coordinate directly with my endocrinologist to adjust my screening schedule if my IGF-1 levels fluctuate?
  4. 4.Are there any additional screenings or specific lifestyle changes you recommend to help mitigate my higher risk for colon polyps?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Increased risk of preneoplastic colonic lesions and colorectal carcinoma in acromegaly: multicenter case-control study.

    Battistone MF, Miragaya K, Rogozinski A, et al.

    Pituitary 2021; (24(1)):96-103 doi:10.1007/s11102-020-01090-8.

    PMID: 33057946
  2. 2

    Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening.

    Hepşen S, Üçgül E, Menekşe B, et al.

    Pituitary 2025; (28(2)):44 doi:10.1007/s11102-025-01513-4.

    PMID: 40167828
  3. 3

    THE PREVALENCE OF COLONIC POLYPS IN PATIENTS WITH ACROMEGALY: A CASE-CONTROL, NESTED IN A COHORT COLONOSCOPIC STUDY.

    Gonzalez B, Vargas G, Mendoza V, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2017; (23(5)):594-599 doi:10.4158/EP161724.OR.

    PMID: 28225314
  4. 4

    Reappraisal of colorectal polyps in acromegaly: study on prevalence, recurrence and risk factors.

    Pirchio R, Auriemma RS, Pivonello C, et al.

    Pituitary 2026; (29(1)):33.

    PMID: 41553573
  5. 5

    Cancer risk in a large acromegaly cohort: a standardized incidence ratio analysis.

    Ercan P, Yazgan BF, Sendur SN, et al.

    Pituitary 2026; (29(4)).

    PMID: 42301595
  6. 6

    Cardiovascular Effects of Excess Growth Hormone: How Real is the Threat?

    Rivera FB, Taliño MK, Ansay MF, et al.

    Reviews in cardiovascular medicine 2023; (24(4)):95 doi:10.31083/j.rcm2404095.

    PMID: 39076279
  7. 7

    Esculetin exerts antitumor effect on human gastric cancer cells through IGF-1/PI3K/Akt signaling pathway.

    Wang G, Lu M, Yao Y, et al.

    European journal of pharmacology 2017; (814()):207-215 doi:10.1016/j.ejphar.2017.08.025.

    PMID: 28847482
  8. 8

    Insulin/IGF-1 enhances intestinal epithelial crypt proliferation through PI3K/Akt, and not ERK signaling in obese humans.

    Zhou W, Rowitz BM, Dailey MJ

    Experimental biology and medicine (Maywood, N.J.) 2018; (243(11)):911-916 doi:10.1177/1535370218785152.

    PMID: 29950119
  9. 9

    Co-delivery of siRNA and lycopene encapsulated hybrid lipid nanoparticles for dual silencing of insulin-like growth factor 1 receptor in MCF-7 breast cancer cell line.

    Mennati A, Rostamizadeh K, Manjili HK, et al.

    International journal of biological macromolecules 2022; (200()):335-349 doi:10.1016/j.ijbiomac.2021.12.197.

    PMID: 34999039
  10. 10

    Acromegaly and the Colon: Scoping Beyond the Pituitary.

    Patel GS, Grossmann I, Rodriguez K, et al.

    Cureus 2021; (13(11)):e20018 doi:10.7759/cureus.20018.

    PMID: 34987906
  11. 11

    Prospective, Longitudinal Study of Cancer Predictors and Rates in a New York City Cohort of 598 Patients With Acromegaly.

    Freda PU, Bruce JN, Jin Z, et al.

    The Journal of clinical endocrinology and metabolism 2025; (110(5)):1247-1257 doi:10.1210/clinem/dgae469.

    PMID: 38986012
  12. 12

    Acromegaly and Colorectal Neoplasm: An Update.

    Kasuki L, Maia B, Gadelha MR

    Frontiers in endocrinology 2022; (13()):924952 doi:10.3389/fendo.2022.924952.

    PMID: 35795151
  13. 13

    Clinical Characteristics and Associated Factors of Colonic Polyps in Acromegaly.

    Peng G, Li X, Zhou Y, et al.

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2022; (130(11)):714-722 doi:10.1055/a-1913-7900.

    PMID: 36075228

This page provides educational information about the link between acromegaly and colon polyps. It does not replace professional medical advice. Always consult your endocrinologist and gastroenterologist regarding your personalized screening schedule.

Get notified when new evidence is published on Acromegaly.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.